GMO Domestic Resilience ETF
DRES
5 hedge funds and large institutions have $30.8M invested in GMO Domestic Resilience ETF in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
150% more funds holding
Funds holding: 2 → 5 (+3)
3% more capital invested
Capital invested by funds: $29.9M → $30.8M (+$890K)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.2% less ownership
Funds ownership: 82.54% → 82.34% (-0.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$287K |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$38.1K |
| 3 |
JP Morgan Chase
New York
|
+$14.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$2.89M |
DRES Hedge Fund Activity: Q2 2026 in Review
5 of the 8,324 institutional investors tracked by Wall St. Rank reported a position in GMO Domestic Resilience ETF (DRES) for Q2 2026, worth a combined $30.8M — up 3% from $29.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DRES positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $287K. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $2.89M.
- 5 institutional investors held GMO Domestic Resilience ETF (DRES) as of Q2 2026, up from 2 in Q1 2026.
- Funds reported $30.8M of GMO Domestic Resilience ETF stock for Q2 2026, up 3% quarter-over-quarter.
- 3 funds opened new GMO Domestic Resilience ETF positions in Q2 2026 and 0 closed out, a net change of +3 holders.
- The largest GMO Domestic Resilience ETF buyer in Q2 2026 was Citadel Advisors, an estimated $287K added.
- The largest GMO Domestic Resilience ETF seller in Q2 2026 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $2.89M sold.
Based on aggregated 13F filings for Q2 2026.